The importance of patient-centred drug development for amyotrophic lateral sclerosis.
Saved in:
| Title: | The importance of patient-centred drug development for amyotrophic lateral sclerosis. |
|---|---|
| Authors: | Kiernan MC; Brain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia.; Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Halliday GM; Brain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, School of Medical Sciences, University of Sydney, Sydney, New South Wales, Australia., Rowe DB; Macquarie University Centre for Motor Neuron Disease Research, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia., Tan RH; Brain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, School of Medical Sciences, University of Sydney, Sydney, New South Wales, Australia. |
| Source: | Neuropathology and applied neurobiology [Neuropathol Appl Neurobiol] 2023 Dec; Vol. 49 (6), pp. e12944. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 7609829 Publication Model: Print Cited Medium: Internet ISSN: 1365-2990 (Electronic) Linking ISSN: 03051846 NLM ISO Abbreviation: Neuropathol Appl Neurobiol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2990 |
|---|---|
| DOI: | 10.1111/nan.12944 |
